CD38 and neoplasm: The mean (SD) and median (range) percentages of tumor cells that expressed CD38 at baseline were 56.7% (39.3) and 60.0% (0–100), respectively, in responders and 41.6% (31.9) and 40.0% (0–100) in nonresponders (Additional file 2: Fig. S1).